Overview

Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer

Status:
Completed
Trial end date:
2019-06-26
Target enrollment:
Participant gender:
Summary
This study is a phase II, single arm, controlled, open label internal pilot.
Phase:
Phase 2
Details
Lead Sponsor:
Sunnybrook Health Sciences Centre
Collaborators:
Sunnybrook Research Institute
University of Toronto
Treatments:
Metformin